SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-011013
Filing Date
2020-07-30
Accepted
2020-07-30 19:02:58
Documents
1
Period of Report
2020-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20200730x8kxnovar.htm 8-K 39534
  Complete submission text file 0001628280-20-011013.txt   40680
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 201061746
SIC: 2836 Biological Products, (No Diagnostic Substances)